Barely Significant
← all excerpts

Intentional internal high-dose policy in VMAT for stage III NSCLC with consolidation durvalumab - a retrospective study.

Rep Pract Oncol Radiother · 2026 · PMC13046416 · PMID 41937882

2
hedged sentences
closest p
boldest claim

The sentences

showed a trendno p-value reported
In patients with large PTVs (≥ 373 cc), IIHDP showed a trend toward improved LRC, though not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.